‘Godzilla’ of weight-loss drugs could provide other important health benefits

Eli Lilly’s experimental drug retatrutide helped people with obesity and type 2 diabetes lose up to 60 pounds, or about 23 percent of their body weight, in late-stage trial results published Tuesday in The Lancet.